Opis działalności
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.
Zarząd & Rada nadzorcza
| CEO |
| Thomas Meier |
| Zarząd |
| Alain Schaffter, Dr. Anne-Kathrin Stoller, Dr. Günther Loidl, Torsten Wohr |
| Rada nadzorcza |
| Dr. Kuno Sommer, Dr. Alex Fässler, Dr. h.c. Peter Grogg, Dr. Steffen Lang, Nicole Grogg Hötzer, Prof. Dr. Helma Wennemers |
Dane firmy
| Nazwa: |
Bachem Holding AG |
| Adres: |
Hauptstraße 144,CH-4416 Bubendorf |
| Telefon: |
+41-58-595-2020 |
| Fax: |
+41-58-595-2040 |
| E-mail: |
sales.ch@bachem.com
|
| Internet: |
www.bachem.com |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
38,00% |
| Data IPO: |
22.07.1998 |
Relacje inwestorskie
| Nazwa: |
Daniel Grotzky |
| Telefon: |
+41-58-595-2021 |
| Fax: |
+41-58-595-2043 |
| E-mail: |
ir@bachem.com
|
